Advertisement
QTRX vs SIBN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTRX is a StrongBuy and SIBN is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
QTRX’s FA Score shows that 1 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).
- QTRX’s FA Score: 1 green, 4 red.
- SIBN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
QTRX’s TA Score shows that 5 TA indicator(s) are bullish while SIBN’s TA Score has 6 bullish TA indicator(s).
- QTRX’s TA Score: 5 bullish, 5 bearish.
- SIBN’s TA Score: 6 bullish, 4 bearish.
Price Growth
QTRX (@Medical/Nursing Services) experienced а +25.94% price change this week, while SIBN (@Medical/Nursing Services) price change was +4.78% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.16%. For the same industry, the average monthly price growth was -2.20%, and the average quarterly price growth was +13.05%.
Reported Earning Dates
QTRX is expected to report earnings on Mar 03, 2026.
SIBN is expected to report earnings on Mar 02, 2026.
Industries' Descriptions
@Medical/Nursing Services (+7.16% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| QTRX | SIBN | QTRX / SIBN | |
| Capitalization | 345M | 846M | 41% |
| EBITDA | -72.89M | -15.81M | 461% |
| Gain YTD | -30.574 | 39.016 | -78% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 124M | 185M | 67% |
| Total Cash | 261M | 146M | 179% |
| Total Debt | 35.5M | 36.9M | 96% |
QTRX | SIBN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 91 | |
PRICE GROWTH RATING 1..100 | 39 | 40 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
QTRX's Valuation (33) in the Pharmaceuticals Major industry is in the same range as SIBN (41) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to SIBN’s over the last 12 months.
QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SIBN (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to SIBN’s over the last 12 months.
SIBN's SMR Rating (91) in the Medical Specialties industry is in the same range as QTRX (92) in the Pharmaceuticals Major industry. This means that SIBN’s stock grew similarly to QTRX’s over the last 12 months.
QTRX's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as SIBN (40) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to SIBN’s over the last 12 months.
QTRX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as SIBN (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to SIBN’s over the last 12 months.
| QTRX | SIBN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 88% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 81% | 1 day ago 76% |
| Advances ODDS (%) | 1 day ago 81% | 7 days ago 75% |
| Declines ODDS (%) | 21 days ago 86% | 15 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 83% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 68% |
Advertisement